You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pibrentasvir

Showing 26 - 50 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Acute Trial in Australia, New Zealand, United Kingdom (Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin)

Recruiting
  • Hepatitis C, Acute
  • Sydney, New South Wales, Australia
  • +10 more
Jun 23, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Strategies for Hepatitis C Testing and Treatment in Aboriginal

Recruiting
  • Hepatitis C
  • +5 more
  • Fingerstick GeneXpert HCV RNA quantitative assay
  • +2 more
  • Lismore, New South Wales, Australia
  • +3 more
Apr 13, 2022

Hepatitis C Trial in New York (Mavyret)

Completed
Has Results
  • Hepatitis C
  • New York, New York
    New York University School of Medicine
Sep 1, 2021

Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir

Completed
  • Kidney Transplant
  • +2 more
  • Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
  • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
  • Columbus, Ohio
    Brenda Cuson
Jul 29, 2021

HCV Infection Trial in Baltimore (Glecaprevir/pibrentasvir)

Withdrawn
  • HCV Infection
  • Baltimore, Maryland
    Baltimore City Detention Center
Apr 30, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 8, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection Trial in Ljubljana (glecaprevir, pibrentasvir)

Approved for marketing
  • Hepatitis C Virus Infection
  • Ljubljana, Slovenia
    Univ Medical Ctr Ljubljana /ID# 161419
Jan 14, 2020

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

Recruiting
  • Hepatitis C Virus (HCV)
  • Glecaprevir/Pibrentasvir (GLE/PIB)
  • Chandler, Arizona
  • +62 more
Aug 8, 2022

Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

Recruiting
  • Hepatitis C Virus Infection, Response to Therapy of
  • Test and treat plus peer mentors
  • Usual care
  • Birmingham, Alabama
  • +3 more
Dec 9, 2022

Hepatitis C Virus (HCV) Trial in Brazil (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Vitoria, Espirito Santo, Brazil
  • +13 more
Mar 4, 2020

Maviret in Adolescent Chronic Hepatitis C Virus

Recruiting
  • Hepatitis C Virus (HCV)
    • Kariya-shi, Aichi, Japan
    • +34 more
    Oct 27, 2022

    Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)

    Completed
    Has Results
    • Hepatitis C
    • HCV
    • Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
    • Ribavirin 200Mg Tablet
    • Palo Alto, California
    • +30 more
    Feb 17, 2020

    Glecaprevir/Pibrentasvir Real-world Study in China

    Unknown status
    • Chronic Hepatitis c
    • (no location specified)
    May 6, 2019

    Hepatitis C, Chronic Trial in Worldwide (glecaprevir (300mg)/pibrentasvir (120mg))

    Completed
    Has Results
    • Hepatitis C, Chronic
    • glecaprevir (300mg)/pibrentasvir (120mg)
    • Boston, Massachusetts
    • +32 more
    Dec 9, 2019

    Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

    Not yet recruiting
    • Hepatitis C
    • Cirrhosis
    • (no location specified)
    Jul 20, 2022

    Glecaprevir Plus Pibrentasvir in Chronic Hepatitis C Genotypes 1

    Completed
    • Hepatitis C
      • Klagenfurt Am Woerthersee, Kaernten, Austria
      • +155 more
      May 18, 2021

      Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

      Completed
      Has Results
      • Hepatitis C Virus (HCV)
      • Phoenix, Arizona
      • +112 more
      Jun 24, 2020